Hyperparathyroidism in reptiles is an endocrine disorder characterized by excessive production and secretion of parathyroid hormone (PTH) by the parathyroid glands, occurring as a compensatory response to disrupted calcium homeostasis rather than as a primary glandular abnormality in most cases. The parathyroid glands, small endocrine structures that regulate blood calcium levels through PTH secretion, become chronically overstimulated when the body cannot maintain adequate calcium levels through normal dietary absorption and metabolic processes. This persistent overactivity leads to pathological calcium mobilization from bones, progressive skeletal weakening, and systemic metabolic dysfunction that affects multiple organ systems.
The condition manifests in two primary forms based on underlying etiology. Secondary nutritional hyperparathyroidism (SNHP) develops from dietary calcium deficiency, improper calcium-to-phosphorus ratios, or inadequate vitamin D3 availability, representing the most common form seen in captive reptiles. Renal secondary hyperparathyroidism occurs when kidney disease impairs the activation of vitamin D and disrupts phosphorus excretion, triggering compensatory parathyroid overactivity. Primary hyperparathyroidism, caused by autonomous parathyroid gland dysfunction or neoplasia, is rare in reptiles but has been documented. Understanding the underlying cause is essential for appropriate treatment selection.
Hyperparathyroidism affects virtually all reptile species maintained in captivity when husbandry fails to provide adequate calcium nutrition, appropriate UVB lighting for vitamin D synthesis, or both. Bearded dragons, iguanas, chameleons, and other species with high calcium requirements are most commonly affected, though the condition occurs across all reptile families. The intimate connection between hyperparathyroidism and metabolic bone disease means these conditions frequently occur together, with hyperparathyroidism representing the hormonal mechanism driving the skeletal manifestations seen in MBD.
Treatment success depends heavily on early detection and correction of underlying causes. Secondary nutritional hyperparathyroidism is often fully reversible when dietary and lighting deficiencies are corrected before permanent skeletal damage occurs. Advanced cases with established bone pathology carry more guarded prognoses, as skeletal remodeling takes months to years and may never fully restore normal architecture. Renal secondary hyperparathyroidism has variable outcomes depending on kidney disease severity and reversibility. A reptile-experienced veterinarian is essential for accurate diagnosis, identification of underlying cause, and development of appropriate treatment protocols.
